CDKN2A and squamous cell carcinoma: Interestingly, 5 out of 6 cases of high-grade squamous cell carcinomas with focal or a single-cell p16 expression also showed loss of Rb1 expression, which might suggest an incomplete activation of p16 protein despite the same p16/Rb1 signaling activation status as observed in small-cell carcinomas.